Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Lee, John D ^a   Kamaruzaman, Nur A ^a   Fung, Jenny N T ^a   Taylor, Stephen M ^a   Turner, Bradley J ^b   Atkin, Julie D ^c   Woodruff, Trent M ^a   Noakes, Peter G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

Author keywords

C1q; C3; C4; C5; CD55; CD88; Factor B; Motor neuron disease; Neuroinflammation

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CD59 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1QB; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A RECEPTOR; DECAY ACCELERATING FACTOR; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; HSOD1 GENE; IMMUNE DYSREGULATION; IMMUNOLOCALIZATION; LUMBAR SPINE; MICROGLIA; MOTONEURON; MOUSE; NERVE CELL NECROSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SPINAL CORD; TRANSGENIC MOUSE; WESTERN BLOTTING; WILD TYPE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BLOTTING, WESTERN; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR NEURONS; REAL-TIME POLYMERASE CHAIN REACTION; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 84884538493     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-119     Document Type: Article

References (56)

1. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004, 27:723-749. 10.1146/annurev.neuro.27.070203.144244, 15217349.
2. Cozzolino M, Ferri A, Carri MT. Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications. Antioxid Redox Signal 2008, 10:405-443. 10.1089/ars.2007.1760, 18370853.
3. Woodruff TM, Costantini KJ, Taylor SM, Noakes PG. Role of complement in motor neuron disease: animal models and therapeutic potential of complement inhibitors. Adv Exp Med Biol 2008, 632:143-158.
4. Lee JD, Lee JY, Taylor SM, Noakes PG, Woodruff TM. Innate Immunity in ALS. Amyotrophic Lateral Sclerosis 2012, 393-412. Croatia: InTech, Maurer MH.
5. Almer G, Guegan C, Teismann P, Naini A, Rosoklija G, Hays AP, Chen C, Przedborski S. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 2001, 49:176-185. 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X, 11220737.
6. Almer G, Teismann P, Stevic Z, Halaschek-Wiener J, Deecke L, Kostic V, Przedborski S. Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology 2002, 58:1277-1279. 10.1212/WNL.58.8.1277, 11971099.
7. McGeer PL, McGeer EG. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 2002, 26:459-470. 10.1002/mus.10191, 12362410.
8. Henkel JS, Beers DR, Wen S, Rivera AL, Toennis KM, Appel JE, Zhao W, Moore DH, Powell SZ, Appel SH. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol Med 2013, 5:64-79. 10.1002/emmm.201201544, 3569654, 23143995.
9. Zhao W, Beers DR, Liao B, Henkel JS, Appel SH. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms. Neurobiol Dis 2012, 48:418-428. 10.1016/j.nbd.2012.07.008, 22820142.
10. Humayun S, Gohar M, Volkening K, Moisse K, Leystra-Lantz C, Mepham J, McLean J, Strong MJ. The complement factor C5a receptor is upregulated in NFL-/- mouse motor neurons. J Neuroimmunol 2009, 210:52-62. 10.1016/j.jneuroim.2009.01.028, 19286267.
11. Woodruff TM, Costantini KJ, Crane JW, Atkin JD, Monk PN, Taylor SM, Noakes PG. The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis. J Immunol 2008, 181:8727-8734.
12. Drummond M, Sorenson C. Nasty or nice? A perspective on the use of health technology assessment in the United Kingdom. Value Health 2009, 12(Suppl 2):S8-S13.
13. Zhou C, Zhao CP, Zhang C, Wu GY, Xiong F. A method comparison in monitoring disease progression of G93A mouse model of ALS. Amyotroph Lateral Scler 2007, 8:366-372. 10.1080/17482960701538759, 17852023.
14. Fogarty MJ, Smallcombe KL, Yanagawa Y, Obata K, Bellingham MC, Noakes PG. Genetic deficiency of GABA differentially regulates respiratory and non-respiratory motor neuron development. PLoS One 2013, 8:e56257. 10.1371/journal.pone.0056257, 3574162, 23457538.
15. Watson C, Paxinos G, Kayalioglu G. The Spinal Cord 2009, London: Academic, 1.
16. Banks GB, Chau TN, Bartlett SE, Noakes PG. Promotion of motoneuron survival and branching in rapsyn-deficient mice. J Comp Neurol 2001, 429:156-165. 10.1002/1096-9861(20000101)429:1<156::AID-CNE12>3.0.CO;2-3, 11086296.
17. Banks GB, Kanjhan R, Wiese S, Kneussel M, Wong LM, OSullivan G, Sendtner M, Bellingham MC, Betz H, Noakes PG. Glycinergic and GABAergic synaptic activity differentially regulate motoneuron survival and skeletal muscle innervation. J Neurosci 2005, 25:1249-1259. 10.1523/JNEUROSCI.1786-04.2005, 15689563.
18. Clarke PG, Oppenheim RW. Neuron death in vertebrate development: in vitro methods. Methods Cell Biol 1995, 46:277-321.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
20. Abramoff MD, Magalhaes PJ, Ram SJ. Image processing with ImageJ. Biophoton Int 2004, 11:36-42.
21. Simmons DG, Rawn S, Davies A, Hughes M, Cross JC. Spatial and temporal expression of the 23 murine prolactin/placental lactogen-related genes is not associated with their position in the locus. BMC Genomics 2008, 9:352. 10.1186/1471-2164-9-352, 2527339, 18662396.
22. Pavlovski D, Thundyil J, Monk PN, Wetsel RA, Taylor SM, Woodruff TM. Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis. Faseb J 2012, 26:3680-3690. 10.1096/fj.11-202382, 22651932.
23. Wu MC, Brennan FH, Lynch JP, Mantovani S, Phipps S, Wetsel RA, Ruitenberg MJ, Taylor SM, Woodruff TM. The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization. Proc Natl Acad Sci U S A 2013, 110:9439-9444. 10.1073/pnas.1218815110, 23696668.
24. Mead RJ, Bennett EJ, Kennerley AJ, Sharp P, Sunyach C, Kasher P, Berwick J, Pettmann B, Battaglia G, Azzouz M, Grierson A, Shaw PJ. Optimised and rapid pre-clinical screening in the SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS). PLoS One 2011, 6:e23244. 10.1371/journal.pone.0023244, 3158065, 21876739.
25. Lepore AC, Haenggeli C, Gasmi M, Bishop KM, Bartus RT, Maragakis NJ, Rothstein JD. Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS. Brain Res 2007, 1185:256-265. 2265207, 17963733.
26. Schafer S, Hermans E. Reassessment of motor-behavioural test analyses enables the detection of early disease-onset in a transgenic mouse model of amyotrophic lateral sclerosis. Behav Brain Res 2011, 225:7-14. 10.1016/j.bbr.2011.06.019, 21723884.
27. Weydt P, Hong SY, Kliot M, Moller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 2003, 14:1051-1054.
28. Woodruff TM, Ager RR, Tenner AJ, Noakes PG, Taylor SM. The role of the complement system and the activation fragment C5a in the central nervous system. Neuromolecular Med 2010, 12:179-192. 10.1007/s12017-009-8085-y, 19763906.
29. Spendlove I, Ramage JM, Bradley R, Harris C, Durrant LG. Complement decay accelerating factor (DAF)/CD55 in cancer. Cancer Immunol Immunother 2006, 55:987-995. 10.1007/s00262-006-0136-8, 16485129.
30. Kimberley FC, Sivasankar B, Paul Morgan B. Alternative roles for CD59. Mol Immunol 2007, 44:73-81. 10.1016/j.molimm.2006.06.019, 16884774.
31. Woodruff TM, Nandakumar KS, Tedesco F. Inhibiting the C5-C5a receptor axis. Mol Immunol 2011, 48:1631-1642. 10.1016/j.molimm.2011.04.014, 21549429.
32. Raivich G. Like cops on the beat: the active role of resting microglia. Trends Neurosci 2005, 28:571-573. 10.1016/j.tins.2005.09.001, 16165228.
33. Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, Estevez AG, Beckman JS. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev 2004, 47:263-274. 10.1016/j.brainresrev.2004.05.003, 15572176.
34. Yasojima K, Schwab C, McGeer EG, McGeer PL. Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am J Pathol 1999, 154:927-936. 10.1016/S0002-9440(10)65340-0, 1866427, 10079271.
35. Singhrao SK, Neal JW, Morgan BP, Gasque P. Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp Neurol 1999, 159:362-376. 10.1006/exnr.1999.7170, 10506508.
36. Ager RR, Fonseca MI, Chu SH, Sanderson SD, Taylor SM, Woodruff TM, Tenner AJ. Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease. J Neurochem 2010, 113:389-401. 10.1111/j.1471-4159.2010.06595.x, 2921960, 20132482.
37. Woodruff TM, Crane JW, Proctor LM, Buller KM, Shek AB, de Vos K, Pollitt S, Williams HM, Shiels IA, Monk PN, Taylor SM. Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration. FASEB J 2006, 20:1407-1417. 10.1096/fj.05-5814com, 16816116.
38. Chiu IM, Phatnani H, Kuligowski M, Tapia JC, Carrasco MA, Zhang M, Maniatis T, Carroll MC. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc Natl Acad Sci U S A 2009, 106:20960-20965. 10.1073/pnas.0911405106, 2791631, 19933335.
39. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, Lambris JD, Smith SJ, John SW, Barres BA. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178. 10.1016/j.cell.2007.10.036, 18083105.
40. Heurich B, El Idrissi NB, Donev RM, Petri S, Claus P, Neal J, Morgan BP, Ramaglia V. Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis. J Neuroimmunol 2011, 235:104-109. 10.1016/j.jneuroim.2011.03.011, 21501881.
41. Dupuis L, Loeffler JP. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr Opin Pharmacol 2009, 9:341-346. 10.1016/j.coph.2009.03.007, 19386549.
42. Cappello V, Vezzoli E, Righi M, Fossati M, Mariotti R, Crespi A, Patruno M, Bentivoglio M, Pietrini G, Francolini M. Analysis of neuromuscular junctions and effects of anabolic steroid administration in the SOD1G93A mouse model of ALS. Mol Cell Neurosci 2012, 51:12-21. 10.1016/j.mcn.2012.07.003, 22800606.
43. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012, 74:691-705. 10.1016/j.neuron.2012.03.026, 3528177, 22632727.
44. Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 2008, 131:1540-1550. 10.1093/brain/awn071, 18469020.
45. Wang Y, Li Y, Dalle Lucca SL, Simovic M, Tsokos GC, Dalle Lucca JJ. Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury. J Neuroinflammation 2010, 7:24. 10.1186/1742-2094-7-24, 2867804, 20380727.
46. Britschgi M, Takeda-Uchimura Y, Rockenstein E, Johns H, Masliah E, Wyss-Coray T. Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice. J Neuroinflammation 2012, 9:220. 10.1186/1742-2094-9-220, 3511294, 22989354.
47. Stahel PF, Flierl MA, Morgan BP, Persigehl I, Stoll C, Conrad C, Touban BM, Smith WR, Beauchamp K, Schmidt OI, Ertel W, Leinhase I. Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice. J Neuroinflammation 2009, 6:2. 10.1186/1742-2094-6-2, 2631471, 19133139.
48. Oppermann M, Gotze O. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors. Immunology 1994, 82:516-521. 1414921, 7835913.
49. Fonseca MI, Ager RR, Chu SH, Yazan O, Sanderson SD, LaFerla FM, Taylor SM, Woodruff TM, Tenner AJ. Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. J Immunol 2009, 183:1375-1383. 10.4049/jimmunol.0901005, 19561098.
50. OBarr SA, Caguioa J, Gruol D, Perkins G, Ember JA, Hugli T, Cooper NR. Neuronal expression of a functional receptor for the C5a complement activation fragment. J Immunol 2001, 166:4154-4162.
51. Crane JW, Baiquni GP, Sullivan RK, Lee JD, Sah P, Taylor SM, Noakes PG, Woodruff TM. The C5a anaphylatoxin receptor CD88 is expressed in presynaptic terminals of hippocampal mossy fibres. J Neuroinflammation 2009, 6:34. 10.1186/1742-2094-6-34, 2780381, 19917081.
52. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19:312-318. 10.1016/0166-2236(96)10049-7, 8843599.
53. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 2007, 10:615-622. 10.1038/nn1876, 3799799, 17435755.
54. Griffin RS, Costigan M, Brenner GJ, Ma CH, Scholz J, Moss A, Allchorne AJ, Stahl GL, Woolf CJ. Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity. J Neurosci 2007, 27:8699-8708. 10.1523/JNEUROSCI.2018-07.2007, 17687047.
55. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2006, 103:16021-16026. 10.1073/pnas.0607423103, 1613228, 17043238.
56. Wu DC, Re DB, Nagai M, Ischiropoulos H, Przedborski S. The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc Natl Acad Sci U S A 2006, 103:12132-12137. 10.1073/pnas.0603670103, 1562547, 16877542.